Clinical Trial Update: Minimally Invasive Biomarker for Asthma Disease Severity

View source ↗

Summary

This completed clinical trial, sponsored by Mayo Clinic, investigates a minimally invasive biomarker to assess asthma disease severity. The study aims to determ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Mayo Clinic | Conditions: Asthma, Healthy | Status: COMPLETED